These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 36291551

  • 21. A novel channelopathy in pulmonary arterial hypertension.
    Olschewski A, Nagaraj C, Olschewski H.
    N Engl J Med; 2013 Nov 28; 369(22):2161. PubMed ID: 24283237
    [No Abstract] [Full Text] [Related]

  • 22. A novel channelopathy in pulmonary arterial hypertension.
    Morita H, Komuro I.
    N Engl J Med; 2013 Nov 28; 369(22):2161-2. PubMed ID: 24283238
    [No Abstract] [Full Text] [Related]

  • 23. KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models.
    West JD, Austin ED, Rizzi EM, Yan L, Tanjore H, Crabtree AL, Moore CS, Muthian G, Carrier EJ, Jacobson DA, Hamid R, Kendall PL, Majka S, Rathinasabapathy A.
    Int J Mol Sci; 2021 May 09; 22(9):. PubMed ID: 34065088
    [Abstract] [Full Text] [Related]

  • 24. The genetic basis of pulmonary arterial hypertension.
    Ma L, Chung WK.
    Hum Genet; 2014 May 09; 133(5):471-9. PubMed ID: 24442418
    [Abstract] [Full Text] [Related]

  • 25. A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension.
    Higasa K, Ogawa A, Terao C, Shimizu M, Kosugi S, Yamada R, Date H, Matsubara H, Matsuda F.
    BMC Pulm Med; 2017 Apr 07; 17(1):57. PubMed ID: 28388887
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension.
    Le Ribeuz H, Masson B, Capuano V, Dutheil M, Gooroochurn H, Boët A, Ghigna MR, De Montpreville V, Girerd B, Lambert M, Mercier O, Chung WK, Humbert M, Montani D, Antigny F.
    Am J Respir Cell Mol Biol; 2022 May 07; 66(5):539-554. PubMed ID: 35175177
    [Abstract] [Full Text] [Related]

  • 29. TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications.
    Olschewski A, Veale EL, Nagy BM, Nagaraj C, Kwapiszewska G, Antigny F, Lambert M, Humbert M, Czirják G, Enyedi P, Mathie A.
    Eur Respir J; 2017 Nov 07; 50(5):. PubMed ID: 29122916
    [Abstract] [Full Text] [Related]

  • 30. Comprehensive identification of signaling pathways for idiopathic pulmonary arterial hypertension.
    Liu B, Zhu L, Yuan P, Marsboom G, Hong Z, Liu J, Zhang P, Hu Q.
    Am J Physiol Cell Physiol; 2020 May 01; 318(5):C913-C930. PubMed ID: 32159364
    [Abstract] [Full Text] [Related]

  • 31. Molecular Analysis of BMPR2, TBX4, and KCNK3 and Genotype-Phenotype Correlations in Spanish Patients and Families With Idiopathic and Hereditary Pulmonary Arterial Hypertension.
    Navas P, Tenorio J, Quezada CA, Barrios E, Gordo G, Arias P, López Meseguer M, Santos-Lozano A, Palomino Doza J, Lapunzina P, Escribano Subías P.
    Rev Esp Cardiol (Engl Ed); 2016 Nov 01; 69(11):1011-1019. PubMed ID: 27453251
    [Abstract] [Full Text] [Related]

  • 32. Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.
    Saint-Martin Willer A, Santos-Gomes J, Adão R, Brás-Silva C, Eyries M, Pérez-Vizcaino F, Capuano V, Montani D, Antigny F.
    J Physiol; 2023 Sep 01; 601(17):3717-3737. PubMed ID: 37477289
    [Abstract] [Full Text] [Related]

  • 33. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.
    Guignabert C, Tu L, Girerd B, Ricard N, Huertas A, Montani D, Humbert M.
    Chest; 2015 Feb 01; 147(2):529-537. PubMed ID: 25644906
    [Abstract] [Full Text] [Related]

  • 34. The Action of Smooth Muscle Cell Potassium Channels in the Pathology of Pulmonary Arterial Hypertension.
    Hayabuchi Y.
    Pediatr Cardiol; 2017 Jan 01; 38(1):1-14. PubMed ID: 27826710
    [Abstract] [Full Text] [Related]

  • 35. The genetics of pulmonary arterial hypertension.
    Austin ED, Loyd JE.
    Circ Res; 2014 Jun 20; 115(1):189-202. PubMed ID: 24951767
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension.
    Haarman MG, Kerstjens-Frederikse WS, Vissia-Kazemier TR, Breeman KTN, Timens W, Vos YJ, Roofthooft MTR, Hillege HL, Berger RMF.
    J Pediatr; 2020 Oct 20; 225():65-73.e5. PubMed ID: 32502478
    [Abstract] [Full Text] [Related]

  • 39. TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation.
    Seyler C, Duthil-Straub E, Zitron E, Gierten J, Scholz EP, Fink RH, Karle CA, Becker R, Katus HA, Thomas D.
    Br J Pharmacol; 2012 Mar 20; 165(5):1467-75. PubMed ID: 21838752
    [Abstract] [Full Text] [Related]

  • 40. Heritable forms of pulmonary arterial hypertension.
    Austin ED, Loyd JE.
    Semin Respir Crit Care Med; 2013 Oct 20; 34(5):568-80. PubMed ID: 24037626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.